Is HS2.DE stock a buy on this oversold bounce setup?

HS2.DE stock shows a technical bounce opportunity around **€74.06** with a Meyka grade B+. Consider position size, a stop near **€68.00**, and targets at **€78.00** and **€87.00**. This is a trade plan, not investment advice.

What are the main valuation metrics for HS2.DE stock?

Key metrics: PE **22.93**, P/S **0.84**, P/B **3.06**, free cash flow per share **3.25**, and debt-to-equity **1.02**. These show reasonable valuation versus the healthcare sector.

How does Meyka AI forecast HS2.DE stock price?

Meyka AI's forecast model projects **€73.29** for 1 year, **€78.57** for 3 years, and **€83.85** for 5 years. These figures are model projections, not guarantees.

What are the top risks for a short-term HS2.DE stock trade?

Top risks: thin XETRA liquidity (avg volume **15.00**), leverage (net debt/EBITDA ~**3.50**), and margin pressure in distribution. Use tight risk controls on entry.

DE Stocks

HS2.DE Henry Schein (XETRA) €74.06 pre-market 18 Mar 2026: oversold bounce setup vs 50-day avg

ByHuzaifa Zahoor March 18, 2026

In pre-market trading on XETRA we see HS2.DE stock at €74.06, a hair above the 50-day average of €71.52 and well above the 200-day average of €66.59. This price position frames a classic oversold-bounce opportunity for short-term traders in Germany. Henry Schein, Inc. (HS2.DE) posts a trailing EPS of 3.23 and a PE of 22.93. We use Meyka AI data and sector context to explain catalysts, valuation, and a practical bounce trade plan for the healthcare distribution and services company.